A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial
OPEN JACC. Cardiovascular interventions | 22 Jul 2018
VF Tapson, K Sterling, N Jones, M Elder, U Tripathy, J Brower, RL Maholic, CB Ross, K Natarajan, P Fong, L Greenspon, H Tamaddon, AR Piracha, T Engelhardt, J Katopodis, V Marques, ASP Sharp, G Piazza and SZ Goldhaber
The aim of this study was to determine the lowest optimal tissue plasminogen activator (tPA) dose and delivery duration using ultrasound-facilitated catheter-directed thrombolysis (USCDT) for the treatment of acute intermediate-risk (submassive) pulmonary embolism.
* Data courtesy of Altmetric.com